MedTrace Logo

A Study of SHR4010 in Patients With Hemodialysis

NCT04099927 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-08-18

No results posted yet for this study

Summary

The study is being conducted to evaluate the safety and pharmacokinetics of SHR0410 in patients with hemodialysis.

Conditions

Interventions

DRUG

SHR0410

SHR0410 monotherapy,given intravenously

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jianjun Zou · Jiangsu HengRui Medicine Co., Ltd.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-28
Primary Completion
2020-04-20
Completion
2020-06-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04099927 on ClinicalTrials.gov